- ASGO 4th International Workshop on Gynecologic Oncology
-
Shibuya Y, Toyoshima , Yaegashi N
- KMID: 2413860
- J Gynecol Oncol.
- 2017 Jan;28(1):e24.
- doi: 10.3802/jgo.2017.28.e24
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Do we need a better marker for successful ovarian cancer surgery?
-
Kang S
- KMID: 2413859
- J Gynecol Oncol.
- 2017 Jan;28(1):e21.
- doi: 10.3802/jgo.2017.28.e21
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers
-
Jeon S, Lee SJ, Lim MC, Song T, Bae J, Kim K, Lee JY, Kim SW, Chang SJ, Lee JM
- KMID: 2413853
- J Gynecol Oncol.
- 2017 Jan;28(1):e6.
- doi: 10.3802/jgo.2017.28.e6
The Surgery Treatment Modality Committee of the Korean Gynecologic Oncology Group has determined to develop a surgical manual to facilitate clinical trials and to improve communication between investigators by standardizing... -
- CITED
-
- Close
- SHARE
-
- Close
- Hysteroscopy in fertility-sparing management for early endometrial cancer: a double-edged sword
-
Park JY
- KMID: 2413857
- J Gynecol Oncol.
- 2017 Jan;28(1):e16.
- doi: 10.3802/jgo.2017.28.e16
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The gate-keeping role of surgeons with regard to endometrial cancers in Lynch syndrome
-
Kim MK
- KMID: 2413858
- J Gynecol Oncol.
- 2017 Jan;28(1):e17.
- doi: 10.3802/jgo.2017.28.e17
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study
-
Nishikawa , Hasegawa K, Yabuno A, Yoshida H, Yasuda M, Kozawa E, Fujiwara K
- KMID: 2413861
- J Gynecol Oncol.
- 2017 Jan;28(1):e25.
- doi: 10.3802/jgo.2017.28.e25
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy
-
Lee M, Choi CH, Chun YK, Kim YH, Lee KB, Lee SW, Shim SH, Song YJ, Roh JW, Chang SJ, Lee JM
- KMID: 2413852
- J Gynecol Oncol.
- 2017 Jan;28(1):e5.
- doi: 10.3802/jgo.2017.28.e5
The Surgery Treatment Modality Committee of the Korean Gynecologic Oncologic Group (KGOG) has determined to develop a surgical manual to facilitate clinical trials and to improve communication between investigators by... -
- CITED
-
- Close
- SHARE
-
- Close
- Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
-
Lee SW, Lee TS, Hong DG, No JH, Park DC, Bae JM, Seong SJ, Shin SJ, Ju W, Lee KH, Lee YK, Cho H, Lee C, Paek J, Kim HJ, Lee JW, Kim JW, Bae DS
- KMID: 2413855
- J Gynecol Oncol.
- 2017 Jan;28(1):e12.
- doi: 10.3802/jgo.2017.28.e12
Clinical practice guidelines for gynecologic cancers have been developed by many organizations. Although these guidelines have much in common in terms of the practice of standard of care for uterine... -
- CITED
-
- Close
- SHARE
-
- Close
- Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer
-
Falcone F, Laurelli G, Losito S, Di Napoli , Granata V, Greggi S
- KMID: 2413849
- J Gynecol Oncol.
- 2017 Jan;28(1):e2.
- doi: 10.3802/jgo.2017.28.e2
OBJECTIVE: To report our 15-year institutional experience of fertility-sparing treatment in young patients with early endometrial cancer (EC) treated by combined hysteroscopic resection and progestin therapy. METHODS: Twenty-eight patients (stage IA,... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
-
Lee YJ, Lee SW, Kim KR, Jung KH, Lee JW, Kim YM
- KMID: 2413850
- J Gynecol Oncol.
- 2017 Jan;28(1):e3.
- doi: 10.3802/jgo.2017.28.e3
OBJECTIVE: Most BRCA1/2 carriers do not undergo risk-reducing salpingo-oophorectomy (RRSO) by the recommended age. This study aimed to find the incidence of precursor lesions and cancer after RRSO. METHODS: We retrospectively... -
- CITED
-
- Close
- SHARE
-
- Close
- Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer
-
Zwakman N, van de Laar R, Van Gorp T, Zusterzeel PL, Snijders M, Ferreira I, Massuger L, Kruitwagen RF
- KMID: 2413854
- J Gynecol Oncol.
- 2017 Jan;28(1):e7.
- doi: 10.3802/jgo.2017.28.e7
OBJECTIVE: In patients with advanced stage epithelial ovarian cancer (EOC) the volume of residual tumor after debulking is known as prognostic factor for survival. We wanted to examine the relationship... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients
-
Mabuchi S, Isohashi F, Okazawa M, Kitada F, Maruoka S, Ogawa K, Kimura T
- KMID: 2413856
- J Gynecol Oncol.
- 2017 Jan;28(1):e15.
- doi: 10.3802/jgo.2017.28.e15
OBJECTIVE: To evaluate the efficacy and toxicity of paclitaxel plus carboplatin (TC)-based concurrent chemoradiotherapy (CCRT) followed by consolidation chemotherapy in the International Federation of Gynecology and Obstetrics (FIGO) stage IIIB/IVA... -
- CITED
-
- Close
- SHARE
-
- Close
- Genetic screening in young women diagnosed with endometrial cancer
-
Pecorino B, Rubino C, Guardalà FVF, Galia A, Scollo P
- KMID: 2413851
- J Gynecol Oncol.
- 2017 Jan;28(1):e4.
- doi: 10.3802/jgo.2017.28.e4
OBJECTIVE: To evaluate the importance of Lynch syndrome associated risk screening in the patients aged less than 50 years affected from endometrial cancer. METHODS: From 2007 to 2014, 41 patients affected... -
- CITED
-
- Close
- SHARE
-
- Close
- Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system
-
Kim DH, Seong SJ, Kim MK, Bae HS, Kim ML, Yun BS, Jung YW, Shim JY
- KMID: 2413848
- J Gynecol Oncol.
- 2017 Jan;28(1):e1.
- doi: 10.3802/jgo.2017.28.e1
OBJECTIVE: To determine whether less invasive endometrial (EM) aspiration biopsy is adequately accurate for evaluating treatment outcomes compared to the dilatation and curettage (D&C) biopsy in early-stage endometrial cancer (EC)... -
- CITED
-
- Close
- SHARE
-
- Close
